Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care

Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care

Vineet Dwivedi, Global Head, Alcon Global Services

Vineet Dwivedi, Global Head, Alcon Global Services in an interaction with India Pharma Outlook, discusses how employee engagement in the pharmaceutical industry has evolved to focus on well-being, flexibility, diversity, and career growth. He highlights leadership’s role in fostering innovation, transparency, and inclusion while emphasizing emerging trends like competency-based development, leadership programs, and structured career paths that enhance workforce commitment, drive innovation, and ensure business success. A global executive with over two decades of experience, he specializes in setting up and leading Global Capability Centers, Lean Six Sigma, and business transformation, with expertise in process excellence, stakeholder management, and strategic leadership.

What are the current trends and best practices in employee engagement within the pharmaceutical industry, and how have these practices evolved over the past few years?

In the pharmaceutical industry, employee engagement has become increasingly vital for fostering innovation, improving productivity, and retaining top talent, particularly in areas like R&D and quality, which are critical for competitive advantage. Over the past few years, several key trends and best practices have emerged, such as Enhanced focus on Employee well-being (physical, mental & psychological well-being), Flexibility - Remote or Hybrid work models, Diversity and Inclusion initiatives, Enhanced career pathways and leadership development, Cross-functional collaboration and employee empowerment and Reward & Recognition system.

In the past, employee engagement focused primarily on compensation and job security. However, the approach has evolved significantly over the last few years to a more holistic and human-centered model that addresses mental health, diversity, career development, and flexibility. The pandemic significantly accelerated this evolution, forcing companies to rethink how they engage employees in a virtual or hybrid working world.

By adopting these engagement practices, pharmaceutical companies, particularly those in eye care, can maintain a competitive advantage through an energized, innovative, and committed workforce. This is crucial for maintaining leadership in R&D and quality, which are key differentiators in the highly competitive and rapidly evolving pharmaceutical industry.

Below are a few Initiatives to provide a Brilliant Associate Experience to attract, integrate, develop and retain employees:

Fostering Work-life Integration through Inclusive Offerings:

Many organizations today recognize that diverse backgrounds and perspectives drive innovation, helping deliver exceptional outcomes. To ensure equal opportunities and a balanced work-life integration, several initiatives have been designed to support associates. Some examples of such practices include:

Flexi-place: Associates are given the flexibility to work in a hybrid style, balancing both professional and personal priorities.

Unlimited Sick Leave: Rather than restricting sick leave to a set number of days, some companies offer an unlimited sick leave policy based on trust and the understanding that associates will act in good faith.

Inclusive Health Coverage: Some organizations provide health insurance that includes coverage for same-sex partners, ensuring equal access to health services for all employees.

Newborn Support: Beyond medical benefits, maternity and paternity leave, some organizations offer special gestures like gift vouchers or greeting cards to celebrate the birth of an associate’s child.

Creche Support: Crèche facilities and reimbursement options are available to assist associates with young children in balancing work and family life.

Holistic Wellness Initiatives:

Many companies today recognize the importance of fostering holistic wellness, especially as employees spend a significant portion of their time at work. The workplace can serve as an ideal setting to encourage healthier lifestyle choices. Examples of wellness initiatives include On-site medical clinics that are available 24/7, Regular annual health checkups for employees, Employee Assistance Programs (EAP) offer counseling services for associates and their families and Special wellness benefits such as providing free or discounted health products for employees.

By fostering these types of initiatives, organizations not only help associates maintain work-life integration but also support their overall well-being, ensuring a healthier and more engaged workforce.

What role does leadership play in fostering a culture of employee engagement in the pharmaceutical sector, and how can leaders effectively drive these initiatives?

Leadership plays a critical role in fostering employee engagement in the pharmaceutical sector. Visionary leaders inspire employees by clearly communicating the company’s mission and purpose, helping them see how their work contributes to larger goals, such as improving patient outcomes in eye care. To drive innovation, leaders must cultivate an environment of creativity, collaboration, and risk-taking, particularly in R&D, where experimentation is essential.

Promoting employee well-being is also key, especially in high-pressure roles like pharmaceutical development. Leaders can boost morale and productivity by encouraging work-life balance and flexible arrangements. Diversity and inclusion (D&I) initiatives are equally important, ensuring that all voices are valued and contributing to better decision-making in areas like R&D and quality control.

Transparent and frequent communication fosters trust, especially in complex, highly regulated environments, while continuous learning and development opportunities keep employees engaged and up-to-date with industry advancements. Finally, recognition and empowerment are crucial; leaders must acknowledge employee achievements and provide autonomy, making employees feel valued and engaged. Leaders can enhance engagement, productivity, and innovation by focusing on these areas.

Best Practices for Leaders to Effectively Drive Engagement Initiatives include Lead by Example, Foster Trust and Transparency, Empower Middle Management, Align Engagement with Business Goals: & Measure and Adapt Engagement Efforts

Leadership is the cornerstone of creating a culture of engagement in the pharmaceutical sector. By providing a clear vision, fostering innovation, promoting well-being, and embracing transparency, leaders can effectively drive engagement initiatives. This boosts employee morale and enhances productivity, innovation, and the company’s ability to maintain a competitive advantage in critical areas like R&D and quality—particularly in specialized fields such as eye care.

Looking ahead, what are the emerging trends and future opportunities for enhancing employee engagement in the pharmaceutical industry, and how might these trends reshape business performance in the coming years?

The pharmaceutical industry is witnessing significant shifts in employee engagement practices, driven by emerging trends that will reshape business performance in the coming years. As organizations prioritize employee experience and engagement, these trends present valuable opportunities to drive innovation, performance, and talent retention.

One key trend is the institutionalization of competency-based development programs, which help individuals progress in their careers. Such initiatives focus on enabling employees to take on leadership roles by developing skills aligned with organizational needs. For instance, programs designed to guide individual contributors into first-line managerial roles or help first-line managers progress to second-line leadership are becoming more common.

Leadership development initiatives for emerging women leaders are another growing trend. Tailored programs that provide immersive learning experiences—combining knowledge sharing, coaching, and hands-on challenges—are designed to equip future leaders with the skills needed to thrive. These initiatives focus on amplifying executive presence, thought leadership, and influence, helping organizations build a strong pipeline of capable leaders.

An increasing number of organizations also leverage Employee Resource Groups (ERGs) to foster inclusivity and build a supportive culture. These associate-led groups, formed around shared interests or dimensions of diversity, offer a platform for employees to connect, share experiences, and develop professionally. ERGs are instrumental in building a sense of community and enabling employees to bring their authentic selves to work.

Gender diversity is another critical focus area, with many organizations implementing programs aimed at empowering women and ensuring they have the resources and support to progress into decision-making roles. Initiatives that create networks and provide mentorship are helping to dismantle barriers and create equal opportunities for women in leadership positions.

Clear career progression frameworks are increasingly important for improving employee engagement and retention. By introducing structured career ladders and title progression systems, organizations provide employees with clear paths to advancement. This approach fosters a sense of purpose and transparency, motivating employees to stay engaged and committed to their roles.

Furthermore, organizations are adopting rigorous talent reviews to ensure business-critical roles are filled with top talent. These processes help identify potential leaders within the organization and build succession pipelines, ensuring the organization is well-positioned for future growth.

These trends will likely continue to shape the way businesses operate in the coming years, creating more inclusive, engaging, and transparent work environments. By investing in leadership development, employee empowerment, and career progression, organizations in the pharmaceutical industry can drive sustained success while fostering a culture of engagement and inclusion.

on the deck

Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

Editor's Guest

Related Articles


© 2025 India Pharma Outlook. All Rights Reserved.